Next-generation extracorporeal membrane oxygenation for multi-organ recovery after refractory cardiac arrest.
Asian cardiovascular & thoracic annals · 2026-04-09 · Other / unclear
Abstract
Introduction: Survival after cardiac arrest and prolonged conventional cardiopulmonary resuscitation remains poor, with out-of-hospital survival rates of only 2%-10%. Conventional veno-arterial extracorporeal membrane oxygenation or extracorporeal cardiopulmonary resuscitation can restore circulation but provides uncontrolled reperfusion, fails to prevent ischemia-reperfusion injury and offers limited physiological monitoring, resulting in inconsistent neurological outcomes. Experimental evidence indicates that tissue viability after prolonged ischemia depends not only on its duration but critically on how reperfusion is performed. Methods: Controlled reperfusion strategies, such as controlled automated reperfusion of the whole body, achieve superior preservation of neurological and multi-organ function. Building on prior single-organ reperfusion research, controlled automated reperfusion of the whole body was developed as a next-generation, portable extracorporeal membrane oxygenation-based platform for multi-organ recovery after cardiac arrest and prolonged conventional cardiopulmonary resuscitation. Results: It integrates (1) advanced extracorporeal circulation with high pressure, high flow, pulsatility and rapid hypothermia; (2) a cytoprotective regimen targeting ischemia and reperfusion injury; (3) real-time hemodynamic, metabolic and temperature monitoring; and (4) a mobile design for rapid deployment. In experimental studies, controlled automated reperfusion of the whole body achieved up to 90% survival with intact neurological function after 20 min of cardiac arrest in porcine models. First clinical applications (since 2017) demonstrated favorable outcomes even after 120 min of conventional cardiopulmonary resuscitation. A recent multicenter European study (n = 69) reported 42% overall survival, with 79% of survivors achieving favorable neurological recovery (Cerebral Performance Category 1-2) at 90 days, particularly in in-hospital cardiac arrest and pre-hospital cannulation subgroups. Conclusion: Controlled automated reperfusion of the whole body thus represents a major advance in resuscitation science, enabling controlled multi-organ recovery after prolonged whole-body ischemia.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
ECMO & mechanical circulatory support · Mortality & survival · Quality of life & function · Temperature management
Related articles
- Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). (Resuscitation, 2015)
- Survival and neurological outcome in patients treated with extracorporeal membrane oxygenation and therapeutic hypothermia: an updated systematic review and meta-analysis. (Front Med (Lausanne), 2026)
- eCPR Combined With Therapeutic Hypothermia Could Improve Survival and Neurologic Outcomes for Patients With Cardiac Arrest: A Meta-Analysis. (Front Cardiovasc Med, 2021)
- An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study. (Crit Care, 2014)
- Reliability of prognostic biomarkers after prehospital extracorporeal cardiopulmonary resuscitation with target temperature management. (Scand J Trauma Resusc Emerg Med, 2021)
- Rewarming From Hypothermic Cardiac Arrest Applying Extracorporeal Life Support: A Systematic Review and Meta-Analysis. (Front Med (Lausanne), 2021)